Razel
-
JB Pharma to acquire entire Razel franchise for Rs 314 crores
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy JB…
Read More »
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy JB…
Read More »